Resveratrol, Metabolic Syndrome, and Gut Microbiota

Overview

Journal Nutrients

Date 2018 Nov 8

PMID 30400297

Citations 106

Authors

Alice Chaplin

Christian Carpene

Josep Mercader

Affiliations

Soon will be listed here.

Abstract

Resveratrol is a polyphenol which has been shown to have beneficial effects on metabolic syndrome-related alterations in experimental animals, including glucose and lipid homeostasis improvement and a reduction in fat mass, blood pressure, low-grade inflammation, and oxidative stress. Clinical trials have been carried out to address its potential; however, results are still inconclusive. Even though resveratrol is partly metabolized by gut microbiota, the relevance of this "forgotten organ" had not been widely considered. However, in the past few years, data has emerged suggesting that the therapeutic potential of this compound may be due to its interaction with gut microbiota, reporting changes in bacterial composition associated with beneficial metabolic outcomes. Even though data is still scarce and for the most part observational, it is promising nevertheless, suggesting that resveratrol supplementation could be a useful tool for the treatment of metabolic syndrome and its associated conditions.

Citing Articles

Resveratrol and Physical Activity: A Successful Combination for the Maintenance of Health and Wellbeing?.

Ruggiero M, Motti M, Meccariello R, Mazzeo F Nutrients. 2025; 17(5).

PMID: 40077707 PMC: 11902109. DOI: 10.3390/nu17050837.

The Effects of Novel Co-Amorphous Naringenin and Fisetin Compounds on a Diet-Induced Obesity Murine Model.

Vasquez-Reyes S, Bernal-Gamez M, Dominguez-Chavez J, Mondragon-Vasquez K, Sanchez-Tapia M, Ordaz G Nutrients. 2025; 16(24.

PMID: 39771046 PMC: 11678459. DOI: 10.3390/nu16244425.

Polyphenols and Microbiota Modulation: Insights from Swine and Other Animal Models for Human Therapeutic Strategies.

Anghel A, Taranu I, Ortan A, Marcu Spinu S, Dragoi Cudalbeanu M, Rosu P Molecules. 2025; 29(24.

PMID: 39770115 PMC: 11678809. DOI: 10.3390/molecules29246026.

The microbiota-gut-brain axis: a potential target in the small-molecule compounds and gene therapeutic strategies for Parkinson's disease.

Jiao F, Zhou L, Wu Z Neurol Sci. 2024; 46(2):561-578.

PMID: 39546084 PMC: 11772541. DOI: 10.1007/s10072-024-07878-x.

Dietary resveratrol improves immunity and antioxidant defense in ewes by regulating the rumen microbiome and metabolome across different reproductive stages.

Li X, Sha Y, Li S, Wang Z, Yang Y, Jiao T Front Immunol. 2024; 15:1462805.

PMID: 39464877 PMC: 11502325. DOI: 10.3389/fimmu.2024.1462805.

References

Wu G, Chen J, Hoffmann C, Bittinger K, Chen Y, Keilbaugh S . Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052):105-8. PMC: 3368382. DOI: 10.1126/science.1208344. View

Turnbaugh P, Gordon J . The core gut microbiome, energy balance and obesity. J Physiol. 2009; 587(Pt 17):4153-8. PMC: 2754355. DOI: 10.1113/jphysiol.2009.174136. View

Schueller K, Pignitter M, Somoza V . Sulfated and Glucuronated trans-Resveratrol Metabolites Regulate Chemokines and Sirtuin-1 Expression in U-937 Macrophages. J Agric Food Chem. 2015; 63(29):6535-45. DOI: 10.1021/acs.jafc.5b01830. View

Alberdi G, Rodriguez V, Teresa Macarulla M, Miranda J, Churruca I, Portillo M . Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet. Nutrition. 2013; 29(3):562-7. DOI: 10.1016/j.nut.2012.09.011. View

Jeon B, Jeong E, Shin H, Lee Y, Lee D, Kim H . Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes. 2012; 61(6):1444-54. PMC: 3357272. DOI: 10.2337/db11-1498. View

Basholli-Salihu M, Schuster R, Mulla D, Praznik W, Viernstein H, Mueller M . Bioconversion of piceid to resveratrol by selected probiotic cell extracts. Bioprocess Biosyst Eng. 2016; 39(12):1879-1885. PMC: 5050249. DOI: 10.1007/s00449-016-1662-1. View

Imamura H, Yamaguchi T, Nagayama D, Saiki A, Shirai K, Tatsuno I . Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus. Int Heart J. 2017; 58(4):577-583. DOI: 10.1536/ihj.16-373. View

Lasa A, Churruca I, Eseberri I, Andres-Lacueva C, Portillo M . Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Mol Nutr Food Res. 2012; 56(10):1559-68. DOI: 10.1002/mnfr.201100772. View

Bhatt J, Thomas S, Nanjan M . Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 2012; 32(7):537-41. DOI: 10.1016/j.nutres.2012.06.003. View

10.

Ozturk E, Karaboga Arslan A, Yerer M, Bishayee A . Resveratrol and diabetes: A critical review of clinical studies. Biomed Pharmacother. 2017; 95:230-234. DOI: 10.1016/j.biopha.2017.08.070. View

11.

Wang B, Sun J, Li L, Zheng J, Shi Y, Le G . Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL/6 mice. Food Funct. 2014; 5(7):1452-63. DOI: 10.1039/c3fo60714c. View

12.

Khodabandehloo H, Seyyedebrahimi S, Nasli Esfahani E, Razi F, Meshkani R . Resveratrol supplementation decreases blood glucose without changing the circulating CD14CD16 monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Nutr Res. 2018; 54:40-51. DOI: 10.1016/j.nutres.2018.03.015. View

13.

Yen G, Chen Y, Chang W, Hsu C . Effects of polyphenolic compounds on tumor necrosis factor-α (TNF-α)-induced changes of adipokines and oxidative stress in 3T3-L1 adipocytes. J Agric Food Chem. 2010; 59(2):546-51. DOI: 10.1021/jf1036992. View

14.

Chen S, Zhao X, Ran L, Wan J, Wang X, Qin Y . Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Dig Liver Dis. 2015; 47(3):226-32. DOI: 10.1016/j.dld.2014.11.015. View

15.

Zhao L . The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol. 2013; 11(9):639-47. DOI: 10.1038/nrmicro3089. View

16.

Cho S, Jung U, Choi M . Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice. Br J Nutr. 2012; 108(12):2166-75. DOI: 10.1017/S0007114512000347. View

17.

Elovaara H, Huusko T, Maksimow M, Elima K, Yegutkin G, Skurnik M . Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate. PLoS One. 2015; 10(11):e0142367. PMC: 4640556. DOI: 10.1371/journal.pone.0142367. View

18.

Wong R, Howe P, Buckley J, Coates A, Kunz I, Berry N . Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis. 2010; 21(11):851-6. DOI: 10.1016/j.numecd.2010.03.003. View

19.

Vogl S, Atanasov A, Binder M, Bulusu M, Zehl M, Fakhrudin N . The Herbal Drug Melampyrum pratense L. (Koch): Isolation and Identification of Its Bioactive Compounds Targeting Mediators of Inflammation. Evid Based Complement Alternat Med. 2013; 2013:395316. PMC: 3600302. DOI: 10.1155/2013/395316. View

20.

Gracia A, Miranda J, Fernandez-Quintela A, Eseberri I, Garcia-Lacarte M, Milagro F . Involvement of miR-539-5p in the inhibition of de novo lipogenesis induced by resveratrol in white adipose tissue. Food Funct. 2016; 7(3):1680-8. DOI: 10.1039/c5fo01090j. View